NEW YORK (Reuters Health) – In general, warfarin anticoagulation is beneficial in septuagenarians with atrial fibrillation, researchers report in a November 28th on-line paper in the American Journal…
NEW YORK (Reuters Health) – Exposure to thienopyridines before cardiac surgery is associated with increased risk of postop stroke, rebleeding and mortality, without any reduction in MI risk,…
NEW YORK (Reuters Health) – Contrary to expectations, left ventricular (LV) pacing is not superior to simultaneous biventricular (BiV) pacing in certain patients with symptoms of heart failure,…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome (ACS) or ST-elevation myocardial infarction (STEMI), the proton pump inhibitor (PPI) esomeprazole is superior to the H2-receptor…
NEW YORK (Reuters Health) – In patients with Kawasaki disease, initial treatment with a combination of intravenous immunoglobulin (IVIG) and ulinastatin reduces the occurrence of coronary artery lesions…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – In the Platelet Inhibition and Patient Outcomes (PLATO) trial, ticagrelor and clopidogrel were associated with similar rates of major bleeding, but ticagrelor was…
NEW YORK (Reuters Health) – Hospital outcomes in patients with an acute coronary syndrome are no different whether they were previously taking an angiotensin-converting enzyme inhibitor or not,…
NEW YORK (Reuters Health) – Drug eluting stents (DES) apparently deliver drug to downstream coronary vessels and reduce the rate new lesion formation therein, a Cleveland Clinic team…
NEW YORK (Reuters Health) – Among stable patients with persistent total occlusion of the infarct-related artery after myocardial infarction, those who undergo late percutaneous coronary intervention (PCI) fare…